logo
Dyne Therapeutics assumed with an Outperform at Raymond James

Dyne Therapeutics assumed with an Outperform at Raymond James

Raymond James analyst Martin Auster assumed coverage of Dyne Therapeutics (DYN) with an Outperform rating and $37 price target as part of a broader research note on selection Biotech names. Risk/reward skews favorably across the sector, though while companies with high PoS – probability of success – lead assets allow for higher conviction, highly attractive skews on less de-risked assets may deliver the most outsized returns, the analyst tells investors in a research note. For the stock, the firm notes that while it is trading at an enterprise value below $1B, Dyne's increasingly clinically-validated FORCE platform offers a compelling long-term risk-reward with proof of concept established on two assets in valuable, high unmet need markets, Raymond James added.
Confident Investing Starts Here:
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Raymond James Lifted PT on ConocoPhillips (COP) Stock
Raymond James Lifted PT on ConocoPhillips (COP) Stock

Yahoo

time13 hours ago

  • Yahoo

Raymond James Lifted PT on ConocoPhillips (COP) Stock

ConocoPhillips (NYSE:COP) is one of the On July 22, Raymond James lifted the price objective on the company's stock to $117 from $109, while keeping an 'Outperform' rating, as reported by The Fly. While there are macro uncertainties, the oil price has, for the time being, witnessed a recovery. Therefore, the firm sees minimal activity changes from management teams. Amidst a volatile macro environment, ConocoPhillips (NYSE:COP) remains confident in the competitive advantages offered by the differentiated portfolio, healthy balance sheet, and disciplined capital allocation framework, which prioritizes returns on and of capital to shareholders. ConocoPhillips (NYSE:COP) believes that its fundamental long-term value proposition remains differentiated. It possesses a deep, durable, and diverse portfolio with decades of high-quality, low-cost supply inventory to develop. Furthermore, the company remains on the cusp of a compelling multi-year FCF growth trajectory, thanks to its high-quality, longer-cycle investments in Alaska and LNG. While we acknowledge the potential of COP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Palantir (PLTR) Stock Soars on 2Q Blowout—But Is It Too Expensive to Buy Now?
Palantir (PLTR) Stock Soars on 2Q Blowout—But Is It Too Expensive to Buy Now?

Yahoo

timea day ago

  • Yahoo

Palantir (PLTR) Stock Soars on 2Q Blowout—But Is It Too Expensive to Buy Now?

Palantir Technologies Inc. (NASDAQ:PLTR) is one of the . On August 5, Raymond James analyst Brian Gesuale reiterated a Market Perform rating on the stock. The rating affirmation follows Palantir's blowout quarter, exceeding across multiple metrics. 'PLTR posted another exceptionally strong 2Q25 and guide that was above our Street high model. The fundamentals were strong with a 7% top-line beat, U.S. commercial growth of 93% and a AEBIT beat of ~15%. The strong AIP momentum and demand across virtually all markets supported management's raised guide (midpoint $4.15B vs. Street at $4.05B) that was 6.4% higher, AEBIT that was 11.6% better and a new FCF expectation of $1.9B (vs. prior $1.7B). Key metrics also impressed with $843M of U.S. Comm TCV closed (up 4% q/q, and 222%+ y/y), U.S. comm RDV of $2.8B (up 145% y/y), net dollar retention of 128%.' A financial analyst working in a modern office, analyzing data to identify trends in the markets. According to the firm, Palantir's momentum is being fueled by both new customer adds (up 43% y/y to 849) and expansion with existing customers considering TTM revenue from top 20 was up 30% y/y to $75M/customer. 'The company is obliterating Rule 40/50 metrics posting 94, is talking about a 10x increase in revenue with a simultaneous reduction in headcount, and has truly established itself as a unicorn in such a way that seeing Palantir execute makes us want to revisit our thesis on Santa Claus and the Easter Bunny!' While the firm is in awe of Palantir's results and future potential, it did note valuation concerns considering the stock has expanded from 7x sales in 2023 to 74x sales currently. The firm continues to look for a better entry point as ' 'fundamental momentum is only gathering steam'. Palantir Technologies Inc. (NASDAQ:PLTR) is a leading provider of artificial intelligence systems. While we acknowledge the potential of PLTR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.

Yeti Holdings (YETI) Gets a Buy from Raymond James
Yeti Holdings (YETI) Gets a Buy from Raymond James

Business Insider

time2 days ago

  • Business Insider

Yeti Holdings (YETI) Gets a Buy from Raymond James

Raymond James analyst Dan Wewer maintained a Buy rating on Yeti Holdings today and set a price target of $37.00. The company's shares closed today at $32.66. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Wewer is ranked #2618 out of 9893 analysts. In addition to Raymond James, Yeti Holdings also received a Buy from William Blair's Phillip Blee in a report issued today. However, on the same day, TD Cowen maintained a Hold rating on Yeti Holdings (NYSE: YETI). Based on Yeti Holdings' latest earnings release for the quarter ending March 29, the company reported a quarterly revenue of $351.13 million and a net profit of $16.61 million. In comparison, last year the company earned a revenue of $341.39 million and had a net profit of $15.86 million

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store